Possible involvement of P-glycoprotein in biliary excretion of CPT-11 in rats

Drug Metabolism and Disposition

Volumn 27, Issue 4, 1999, Pages 440-441

  Sugiyama, Yuichi ^a   Chu, Xiao Yan ^a   Kato, Yukio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENYLGLUTATHIONE; ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; GLUTATHIONE DERIVATIVE; GLYCOPROTEIN P; IRINOTECAN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL;

ANIMAL CELL; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG UPTAKE; INTRAHEPATIC BILE DUCT; MALE; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BILE; CAMPTOTHECIN; GLUTATHIONE; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

ANIMALIA;

EID: 0344267659     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Alexander M, der Bliek V and Borst P (1989) Multidrug resistance. Adv Cancer Res 52:165-203.
2. Böhme M, Büchler M, Müller M and Keppler D (1993) Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 333:193-196.
3. Chu XY, Kato Y, Niinuma K, Sudo Kl, Hakusui H and Sugiyama Y (1997a) Multispecific organic anion transporter (cMOAT) is responsible for biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J Pharmacol Exp Ther 281:304-314.
4. Chu XY, Kato Y and Sugiyama Y (1997b) Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. Cancer Res 57:1934-1938.
5. Chu XY, Suzuki H, Ueda K, Kato Y, Akiyarna S and Sugiyama Y (1999) Active efflux of CPT-11 and its metabolites in human KB-derived cell lines. J Pharmacol Exp Ther 288:735-741.
6. Fassberg J and Stella VJ (1992) A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 81:676-684.
7. Gupta E, Safa AR, Wang X and Ratain MJ (1996) Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A. Cancer Res 56:1309-1314.
8. Kaneda N and Yokokura T (1990) Nonlinear pharmacokinetics of CPT-11 in rats. Cancer Res 50:1721-1725.
9. Kojima A, Shinkai T and Saijo N (1993) Cytogenetic effects of CPT-11 and its active metabolites, SN-38 on human lymphocytes. Jpn J Clin Oncol 23:116-122.
10. Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L and Chen G (1997) Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chem Pharmacol 40:S13-S19.
11. Slichenmyer WJ, Rowinsky EK, Donehower RC and Kaufmann SH (1993) The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst. 85:271-291.
12. Vore M, Huffman T and Gosland M (1996) ATP-dependent transport of β-estradiol 17-(β-D-glucuronide) in rat canalicular membrane vesicles. Am J Physiol 271:G791-G798.